In a well designed clinical trial of treatment of ovarian cancer, remission rate at one year is similar for a new drug and usual care, The P-value is 0.4. This means that
Both treatments are effective Neither treatment is effective The statistical power of study is 60% The best estimate treatment effect is 0.4